Core Viewpoint - The company clarifies that recent media reports regarding its humanoid robot core component business entering commercial production are inaccurate and misinterpret its statements [1] Group 1: Company Operations - The company's main business remains focused on the research, development, production, and sales of automotive chassis system components [1] - There are currently no orders or generated revenue from the company's intelligent bionic joint arm products [1] Group 2: Media Misinterpretation - The media reports incorrectly stated that the intelligent bionic joint arm products have entered the mass production stage and that there are over a thousand intended orders in the biopharmaceutical experimental equipment sector [1] - The company emphasizes that the intelligent bionic joint arm products have not yet reached mass production and that significant progress is still required before this can occur [1]

Core Viewpoint - The company clarifies that recent media reports regarding its humanoid robot core component business entering commercial production are inaccurate and misinterpreted [1] Group 1: Company Operations - The company's main business remains focused on the research, production, and sales of automotive chassis system components [1] - There are currently no orders or generated revenue from the intelligent bionic joint arm products [1] Group 2: Media Misinterpretation - The media reports incorrectly stated that the intelligent bionic joint arm product has received over a thousand order intentions in the biopharmaceutical experimental equipment sector [1] - The company emphasizes that the intelligent bionic joint arm product has not yet entered the mass production stage and is still far from achieving it [1]

Core Viewpoint - The company clarifies that recent media reports regarding its humanoid robot core component business entering commercial production are based on misinterpretation, emphasizing that its main business remains automotive chassis system components and that there are currently no orders or revenue from the robotic products [1] Group 1 - The company announced that it will contact media outlets to request the removal of false statements and pursue accountability for the misinformation [1] - Since January 1, 2026, the company's stock has increased by 16.07%, outperforming both the industry and the Shanghai Composite Index during the same period [1] - The company advises investors to remain cautious regarding potential risks associated with the misinformation [1]

Core Viewpoint - The company issued a clarification announcement refuting media reports about its release of an intelligent bionic joint arm, confirming that its main business remains focused on the research, production, and sales of automotive chassis system components [1] Group 1 - The company's main business has not changed and continues to focus on automotive chassis system components [1] - The intelligent bionic joint arm product currently has no orders and has not generated any operating revenue [1] - The media reports contained inaccurate wording, indicating that the product has not yet entered mass production and there is still a long way to go before it can [1]